Skip to main content

MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

01 Oct 2024 Evaluate

Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release about Sun Pharma entering into a global exclusive commercialization, license, and supply agreement for commercializing the specialty product FIBROMUN with Philogen S.p.A, which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..